Kumar, Princy N <br/><br/>
A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study).  [electronic resource] 

 -  AIDS research and therapy  Apr 2009 
 - 3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1742-6405 
<br/><br/><label>Standard No.: </label>10.1186/1742-6405-6-3  doi